Eli Lilly and Co (LLY)
749.91
-3.50
(-0.46%)
USD |
NYSE |
Nov 21, 16:00
748.85
-1.06
(-0.14%)
After-Hours: 20:00
Eli Lilly Max Drawdown (5Y): 22.48% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 22.48% |
| September 30, 2024 | 22.48% |
| August 31, 2024 | 22.48% |
| July 31, 2024 | 22.48% |
| June 30, 2024 | 22.48% |
| May 31, 2024 | 22.48% |
| April 30, 2024 | 22.48% |
| March 31, 2024 | 22.48% |
| February 29, 2024 | 22.48% |
| January 31, 2024 | 22.48% |
| December 31, 2023 | 22.48% |
| November 30, 2023 | 22.48% |
| October 31, 2023 | 22.48% |
| September 30, 2023 | 22.48% |
| August 31, 2023 | 22.48% |
| July 31, 2023 | 22.48% |
| June 30, 2023 | 22.48% |
| May 31, 2023 | 22.48% |
| April 30, 2023 | 22.48% |
| March 31, 2023 | 22.48% |
| February 28, 2023 | 22.48% |
| January 31, 2023 | 22.48% |
| December 31, 2022 | 22.48% |
| November 30, 2022 | 22.48% |
| October 31, 2022 | 22.48% |
| Date | Value |
|---|---|
| September 30, 2022 | 22.48% |
| August 31, 2022 | 22.48% |
| July 31, 2022 | 22.48% |
| June 30, 2022 | 22.48% |
| May 31, 2022 | 22.48% |
| April 30, 2022 | 22.48% |
| March 31, 2022 | 22.48% |
| February 28, 2022 | 22.48% |
| January 31, 2022 | 22.48% |
| December 31, 2021 | 22.48% |
| November 30, 2021 | 22.85% |
| October 31, 2021 | 24.25% |
| September 30, 2021 | 24.25% |
| August 31, 2021 | 24.25% |
| July 31, 2021 | 24.25% |
| June 30, 2021 | 24.25% |
| May 31, 2021 | 24.25% |
| April 30, 2021 | 24.25% |
| March 31, 2021 | 24.25% |
| February 28, 2021 | 24.25% |
| January 31, 2021 | 24.25% |
| December 31, 2020 | 24.25% |
| November 30, 2020 | 24.25% |
| October 31, 2020 | 24.25% |
| September 30, 2020 | 24.25% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
22.48%
Minimum
Dec 2021
24.25%
Maximum
Nov 2019
23.20%
Average
22.48%
Median
Dec 2021
Max Drawdown (5Y) Benchmarks
| Amgen Inc | 24.86% |
| Biogen Inc | 58.04% |
| Johnson & Johnson | 27.36% |
| Viking Therapeutics Inc | 89.26% |
| Moderna Inc | -- |